Evaluation of serum lipid concentrations among U.S. Workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin

Archives of Environmental Health

Volumn 51, Issue 2, 1996, Pages 100-107

  Calvert, Geoffrey M ^a   Wille, Kathleen K ^a   Sweeney, Marie Haring ^a   Halperin, William E ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 2,4,5 TRICHLOROPHENOL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY BURDEN; CHEMICAL INDUSTRY; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

EID: 0029912955     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.1080/00039896.1996.9936001     Document Type: Article

References (26)

1. Neaton JD, Kuller LH, Wentworth D, et al. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years (MRFIT). Am Heart J 1984; 108:759-69.
2. Kannel WB, Castelli W, Gordon T, et al. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971; 74:1-12.
3. Brunzell JD. Disorders of lipoprotein metabolism. In: Wyngaar- den JB, Smith LH Jr., Bennett CJ, Plum F, Eds. Cecil Textbook of Medicine. 19th ed. Philadelphia, PA: Saunders, 1992: pp 1082-90.
4. Cooper GR, Myers GL, Smith SJ, et al. Blood lipid measurements: variations and practical utility. JAMA 1992; 267:1652-60.
5. DeCaprio AP, McMartin DN, O’Keefe PW, et al. Subchronic oral toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the guinea pig: comparisons with a PCB-containing transformer fluid pyrolysate. Fund Appl Tox 1986; 6:454-63.
6. Zinkl JG, Vos JG, Moore JA, Gupta BN. Hematologic and clinical chemistry effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals. Environ Health Perspect 1973; 5:111-18.
7. Buu-Hoi NP, Chanh P, Sesque G, et al. Enzymatic functions as targets of the toxicity of “dioxin” (2,3,7,8-tetrachlorodibenzo- p-dioxin). Naterwissenschaften 1972; 59:173-74.
8. Schiller CM, Adcock CM, Moore RA, et al. Effect of 2,3,7,8-tetra- chlorodibenzo-p-dioxin (TCDD) and fasting on body weight and lipid parameters in rats. Toxicol Appl Pharmacol 1985; 81: 356-61.
9. Poli A, Francescieni G, Puglise L, et al. Increased total and high density lipoprotein cholesterol with apoprotein changes resembling streptozotocin diabetes in tetrachlorodibenzodioxin (TCDD) treated rats. Biochem Pharmacology 1980; 29:835-38.
10. Brewster DW, Bombick DW, Matsumura F. Rabbit serum triglyc- eridemia after administration of 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD). J Toxicol Environ Health 1988; 25:495-507.
11. Olson JR, Hölscher MA, Neal RA. Toxicity of 2,3,7,8-tetra- chlorodibenzo-p-dioxin in the golden Syrian hamster. Tox Appl Pharmacol 1980; 55:67-78.
12. Roegner RH, Grubbs WD, Lustik MB, et al. The Air Force Health Study: An Epidemiologic Investigation of Health Effects in Air Force Personnel Following Exposure to Herbicides. Serum Dioxin Analysis of 1987 Examination Results. Springfield, VA: National Technical Information Service Publication; 1991; Publication ADA-237-519.
13. Martin JV. Lipid abnormalities in workers exposed to dioxin. Br J Ind Med 1984;41:254-56.
14. Moses M, Lilis R, Crow KD, et al. Health status of workers with past exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the manufacture of 2,4,5-trichlorophenoxy-acetic acid. Comparison of findings with and without chloracne. Am J Ind Med 1984; 5:161-82.
15. Suskind RR, Hertzberg VS. Human health effects of 2,4,5-T and its toxic contaminants. JAMA 1984; 251:2372-80.
16. Hoffman RE, Stehr-Green PA, Webb KB, et al. Health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. JAMA 1986; 255:2031-38.
17. Mocarelli P, Marocchi A, Brambilla P, et al. Clinical laboratory manifestations of exposure to dioxin in children. A six-year study of the effects of an environmental disaster near Seveso, Italy. JAMA 1986; 256:2687-95.
18. Sweeney MH, Fingerhut MA, Connally LB, et. al. Progress of the NIOSH cross-sectional medical study of workers occupationally exposed to chemicals contaminated with 2,3,7,8-TCDD. Chemosphere 1989; 19:973-77.
19. Phillips DL, Pirkle JL, Burse VW, Bernert JT, Henderson LO, Needham LL. Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol 1989; 18:495-500.
20. Expert Panel. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36-69.
21. Castelli WP. Epidemiology of coronary artery disease: the Framingham study. Am J Med 1984; 76(2A):4-12.
22. Calvert GM, Sweeney MH, Morris JA, Fingerhut MA, Hornung RW, Halperin WE. Evaluation of chronic bronchitis, chronic obstructive pulmonary disease (COPD) and ventilatory function among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am Rev Respir Dis 1991; 144:1302-06.
23. Russell RM. Nutritional assessment. In: Wyngaarden JB, Smith LH Jr., Bennett CJ, Plum F, Eds. Cecil Textbook of Medicine. 19th ed. Philadelphia, PA: Saunders, 1992; pp 1151-55.
24. Razderova-Vejlupkova J, Nemicova M, Pickova J, et al. The development and prognosis of chronic intoxication by tetrachloro- dibenzo-p-dioxin in man. Arch Environ Health 1981; 36: 5-11.
25. May G. Tetrachlorodibenzodioxin: a survey of subjects ten years after exposure. Br J Ind Med 1982; 39:128-35.
26. Webb KB, Evans RG, Knutsen AP, et al. Medical evaluation of subjects with known body levels of 2,3,7,8-tetrachlorodiben- zo-p-dioxin. J Tox Environ Health 1989; 28:183-93.